Brain Disease Breakthrough from Israel’s Technion
In a groundbreaking discovery, researchers from the Technion-Israel Institute of Technology, in partnership with Cincinnati Children’s Hospital Medical Center (CCHMC), found out how to rescue functional and structural connectivity, and reduce cognitive impairments of brain diseases with drug treatment.
The researchers, Prof. Itamar Kahn of the Technion’s Rappaport Faculty of Medicine in Israel and Prof. Nancy Ratner of Cincinnati Children’s Hospital Medical Center (CCHMC), claimed that such a breakthrough demonstrates a potential new treatment for cognitive damages in the brain white matter, the areas of the central nervous system.
The brain white matter, contains millions of nerve fibers, or axons, that connect other parts of the brain and spinal cord and signal your nerves to talk to one another. A fatty material called myelin protects the fibers and gives white matter its color. (JPost / VFI News)
“God, we ask that you bless this research—that it may help preserve cognition and quality of life for the thousands of children each year who are affected by terrible afflictions of the brain.”